Results 91 to 100 of about 13,529 (168)

Real-World Long-Term Safety of Statin-Fibrate Combination Therapy in Older Patients (≥75 Years): A European Cohort Analysis. [PDF]

Geriatrics (Basel)
Papadopoulos N, Doupis J, Angelopoulos T, Tsougos E, Tembra MS, Diaz JL, Guerrero DB, Sanchez-Calavera MA, Alvarez JCG, Iniesta AR, Redondo S, Ruiz Garcia A, Diaz JA, Rados DZ, Garcia PA, Ibarretxe D, Fraille B, Moliner JMT, Cobo LEM, Barreda MJ, Frigola JL, Gomez Peralta F, Moreno JC, Font N, Fernandez A, Requena JMR, Porta J, Da Silva S, De Niet S.   +28 more
europepmc   +1 more source

Fenofibrate-associated rhabdomyolysis complicated by dialysis-requiring acute kidney injury presenting with atypical clinical manifestations: A case report and literature review. [PDF]

Medicine (Baltimore)
Fang Y, Jiang Y.
europepmc   +1 more source

Association Between the Triglyceride-to-HDL Cholesterol Ratio and Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Real-World Retrospective Study. [PDF]

Biomedicines
Erol A, Şahin MF.
europepmc   +1 more source

Preparation and Characterization of Fenofibric Acid-Loaded Electrospun Fibrous Mats. [PDF]

Nanomaterials (Basel)
Bitay E, Tóth G, Szabó ZI.
europepmc   +1 more source

Managing remnant cholesterol: role of fenofibrate-statin therapy in reducing triglyceride-rich lipoproteins. [PDF]

Front Cardiovasc Med
Raja V, Aguiar C, Alsayed N, Chibber YS, ElBadawi H, Farnier M, Pushpa K, Tokgözoglu L, Zambon A, Berrou JP, Hermans MP.   +10 more
europepmc   +1 more source

Effects of L-Carnitine and Fenofibrate on Lipid Metabolism, Oxidative Status, and Flesh Quality of Yellow River Carp (<i>Cyprinus carpio</i>). [PDF]

Aquac Nutr
Zhao M, Zhi S, Qin C, Yang L, Nie G.
europepmc   +1 more source

A systems-level integration of liver-kidney transcriptomics and genome-scale metabolic models reveals organ-specific injury mechanisms. [PDF]

Front Toxicol
Pannala VR, Hari A, Auerbach SS, Wallqvist A.   +3 more
europepmc   +1 more source

Fenofibrate discontinuation and the association with clinical outcomes in primary biliary cholangitis patients receiving combination therapy. [PDF]

Int J Clin Pharm
Su S, Yang J, Luo J, Yang C, Li C, Liu X, Guo G, Han Y.   +7 more
europepmc   +1 more source

Fenofibrate attenuates hyperhomocysteinemia-potentiated thrombosis by restoring platelet fatty acid β-oxidation. [PDF]

Redox Biol
Han L, Du X, Yan Y, Zhang L, Feng J, Wang X, Zhang X.   +6 more
europepmc   +1 more source

Comparison of pharmacokinetics and safety of fixed-dose versus loose combination of atorvastatin/fenofibrate 10/145 mg in healthy Korean participants. [PDF]

Transl Clin Pharmacol
Jang H, Khwarg J, Huh KY, Park DM, Park H, Yu KS.   +5 more
europepmc   +1 more source